|
|
dna metabolic process
|
GO:0006259 |
303 |
0.794
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.453
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.434
|
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.416
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.399
|
|
|
|
histone lysine demethylation
|
GO:0070076 |
13 |
0.269
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.262
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.244
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.222
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.215
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.206
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.203
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.200
|
|
|
|
regulation of planar cell polarity pathway involved in axis elongation
|
GO:2000040 |
3 |
0.186
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.184
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.176
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.170
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.169
|
|
|
|
genitalia development
|
GO:0048806 |
37 |
0.165
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.164
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.161
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.153
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.152
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.143
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.139
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.137
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.127
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.126
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.126
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.121
|
|
|
|
meiosis i
|
GO:0007127 |
60 |
0.117
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.113
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.108
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.103
|
|
|
|
translation
|
GO:0006412 |
93 |
0.103
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.097
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.097
|
|
|
|
pole plasm assembly
|
GO:0007315 |
2 |
0.094
|
|
|
|
inter male aggressive behavior
|
GO:0002121 |
3 |
0.094
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.093
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.091
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.089
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.087
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.084
|
|
|
|
protein alkylation
|
GO:0008213 |
81 |
0.083
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.083
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.082
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.080
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.078
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.078
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.078
|
|
|
|
antigen receptor mediated signaling pathway
|
GO:0050851 |
64 |
0.077
|
|
|
|
mrna metabolic process
|
GO:0016071 |
84 |
0.076
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.073
|
|
|
|
cardiac muscle hypertrophy
|
GO:0003300 |
23 |
0.073
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.070
|
|
|
|
synaptic vesicle localization
|
GO:0097479 |
59 |
0.070
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.070
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.069
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.069
|
|
|
|
establishment or maintenance of cytoskeleton polarity
|
GO:0030952 |
2 |
0.067
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.067
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.067
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.066
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.066
|
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
46 |
0.065
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.064
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.064
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.062
|
|
|
|
positive regulation of cell proliferation involved in heart valve morphogenesis
|
GO:0003251 |
1 |
0.062
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.062
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.060
|
|
|
|
regulation of transforming growth factor beta2 production
|
GO:0032909 |
2 |
0.059
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.059
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.057
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.056
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.055
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.055
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.054
|
|
|
|
cell cycle checkpoint
|
GO:0000075 |
47 |
0.054
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.053
|
|
|
|
rna splicing
|
GO:0008380 |
54 |
0.053
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.052
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.052
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.051
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.050
|
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
61 |
0.050
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.049
|
|
|
|
mrna splicing via spliceosome
|
GO:0000398 |
43 |
0.049
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.049
|
|
|
|
regulation of mrna processing
|
GO:0050684 |
41 |
0.048
|
|
|
|
neurotransmitter secretion
|
GO:0007269 |
62 |
0.048
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.047
|
|
|
|
rna splicing via transesterification reactions
|
GO:0000375 |
43 |
0.047
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.047
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.046
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.046
|
|
|
|
negative regulation of mapk cascade
|
GO:0043409 |
65 |
0.046
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.045
|
|
|
|
neuroepithelial cell differentiation
|
GO:0060563 |
37 |
0.045
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.045
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.045
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.045
|
|
|
|
mrna processing
|
GO:0006397 |
63 |
0.044
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.044
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.044
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.044
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.044
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.043
|
|
|
|
axon target recognition
|
GO:0007412 |
4 |
0.043
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.043
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.042
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.040
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.040
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.040
|
|
|
|
activation of innate immune response
|
GO:0002218 |
56 |
0.039
|
|
|
|
rab protein signal transduction
|
GO:0032482 |
1 |
0.039
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.039
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.039
|
|
|
|
dna recombination
|
GO:0006310 |
92 |
0.039
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.038
|
|
|
|
dna integrity checkpoint
|
GO:0031570 |
28 |
0.038
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.037
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.036
|
|
|
|
dna repair
|
GO:0006281 |
107 |
0.036
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.036
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.036
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.036
|
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.035
|
|
|
|
pigmentation
|
GO:0043473 |
71 |
0.035
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.035
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.034
|
|
|
|
immune response regulating cell surface receptor signaling pathway
|
GO:0002768 |
80 |
0.034
|
|
|
|
regulation of protein stability
|
GO:0031647 |
52 |
0.032
|
|
|
|
establishment or maintenance of microtubule cytoskeleton polarity
|
GO:0030951 |
1 |
0.032
|
|
|
|
mitotic nuclear division
|
GO:0007067 |
48 |
0.032
|
|
|
|
neurotransmitter transport
|
GO:0006836 |
76 |
0.032
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.032
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.032
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.032
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.032
|
|
|
|
immune response activating cell surface receptor signaling pathway
|
GO:0002429 |
72 |
0.032
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.031
|
|
|
|
stem cell fate specification
|
GO:0048866 |
3 |
0.031
|
|
|
|
chromatin silencing
|
GO:0006342 |
15 |
0.031
|
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.031
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.030
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.030
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.030
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.030
|
|
|
|
regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903050 |
56 |
0.030
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.030
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.030
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.029
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.029
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.029
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.029
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.029
|
|
|
|
natural killer cell activation
|
GO:0030101 |
44 |
0.029
|
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.029
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.028
|
|
|
|
negative regulation of protein catabolic process
|
GO:0042177 |
36 |
0.028
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.028
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.028
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.028
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.028
|
|
|
|
muscle hypertrophy
|
GO:0014896 |
24 |
0.028
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.028
|
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.028
|
|
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.028
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.028
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.027
|
|
|
|
regulation of toll like receptor 4 signaling pathway
|
GO:0034143 |
4 |
0.027
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.027
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.026
|
|
|
|
regulation of response to dna damage stimulus
|
GO:2001020 |
34 |
0.026
|
|
|
|
establishment of vesicle localization
|
GO:0051650 |
81 |
0.026
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.026
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.026
|
|
|
|
dna damage checkpoint
|
GO:0000077 |
26 |
0.026
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.026
|
|
|
|
rna splicing via transesterification reactions with bulged adenosine as nucleophile
|
GO:0000377 |
43 |
0.026
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.026
|
|
|
|
oocyte anterior posterior axis specification
|
GO:0007314 |
2 |
0.026
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.025
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.025
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.025
|
|
|
|
respiratory gaseous exchange
|
GO:0007585 |
43 |
0.025
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.025
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.025
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.025
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.025
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.025
|
|
|
|
establishment of synaptic vesicle localization
|
GO:0097480 |
57 |
0.025
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.024
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.024
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.024
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.024
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.024
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.024
|
|
|
|
circadian regulation of gene expression
|
GO:0032922 |
48 |
0.024
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.024
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.024
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.024
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.023
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.023
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.023
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.023
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.023
|
|
|
|
tolerance induction to self antigen
|
GO:0002513 |
4 |
0.023
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.023
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.023
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.023
|
|
|
|
uterus morphogenesis
|
GO:0061038 |
2 |
0.023
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.023
|
|
|
|
regulation of mrna metabolic process
|
GO:1903311 |
43 |
0.023
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.022
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.022
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.022
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.022
|
|
|
|
regulation of translation
|
GO:0006417 |
71 |
0.022
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.022
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.022
|
|
|
|
trna wobble base modification
|
GO:0002097 |
2 |
0.022
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.022
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.022
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.021
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.021
|
|
|
|
demethylation
|
GO:0070988 |
23 |
0.021
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.021
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.021
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.021
|
|
|
|
negative regulation of t cell proliferation
|
GO:0042130 |
38 |
0.021
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.021
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.020
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.020
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.020
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.019
|
|
|
|
retinal ganglion cell axon guidance
|
GO:0031290 |
18 |
0.019
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.019
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.019
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.019
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.019
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.019
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.019
|
|
|
|
intracellular mrna localization
|
GO:0008298 |
4 |
0.018
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.018
|
|
|
|
protein dna complex subunit organization
|
GO:0071824 |
28 |
0.018
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.018
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.018
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.018
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.018
|
|
|
|
synaptic vesicle transport
|
GO:0048489 |
57 |
0.018
|
|
|
|
cochlear nucleus development
|
GO:0021747 |
4 |
0.017
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.017
|
|
|
|
multi organism behavior
|
GO:0051705 |
62 |
0.017
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.017
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.017
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.017
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.017
|
|
|
|
regulation of proteasomal ubiquitin dependent protein catabolic process
|
GO:0032434 |
40 |
0.017
|
|
|
|
granulocyte differentiation
|
GO:0030851 |
17 |
0.017
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.017
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.017
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.017
|
|
|
|
positive regulation of protein catabolic process
|
GO:0045732 |
60 |
0.016
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.016
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.016
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.016
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.016
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.016
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.016
|
|
|
|
negative regulation of smoothened signaling pathway
|
GO:0045879 |
25 |
0.016
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.016
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.016
|
|
|
|
lymphocyte homeostasis
|
GO:0002260 |
64 |
0.016
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.016
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.016
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.015
|
|
|
|
multi organism reproductive behavior
|
GO:0044705 |
29 |
0.015
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.015
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.015
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.015
|
|
|
|
t cell receptor signaling pathway
|
GO:0050852 |
46 |
0.015
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.015
|
|
|
|
chromosome segregation
|
GO:0007059 |
48 |
0.015
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.015
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.015
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.015
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.015
|
|
|
|
positive regulation of macroautophagy
|
GO:0016239 |
3 |
0.015
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.015
|
|
|
|
gall bladder development
|
GO:0061010 |
2 |
0.015
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.015
|
|
|
|
face development
|
GO:0060324 |
38 |
0.014
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.014
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.014
|
|
|
|
ventricular cardiac myofibril assembly
|
GO:0055005 |
3 |
0.014
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.014
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.014
|
|
|
|
negative regulation of translation
|
GO:0017148 |
22 |
0.014
|
|
|
|
b cell proliferation
|
GO:0042100 |
53 |
0.014
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.014
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.014
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.014
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.014
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
58 |
0.014
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.014
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.014
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.013
|
|
|
|
natural killer cell differentiation
|
GO:0001779 |
21 |
0.013
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.013
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.013
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.013
|
|
|
|
muscle adaptation
|
GO:0043500 |
39 |
0.013
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.013
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.013
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.013
|
|
|
|
regulation of dna templated transcription in response to stress
|
GO:0043620 |
9 |
0.013
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.013
|
|
|
|
toll like receptor 3 signaling pathway
|
GO:0034138 |
4 |
0.013
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.013
|
|
|
|
negative regulation of proteasomal ubiquitin dependent protein catabolic process
|
GO:0032435 |
15 |
0.013
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.013
|
|
|
|
embryonic digestive tract development
|
GO:0048566 |
27 |
0.013
|
|
|
|
regulation of proteasomal protein catabolic process
|
GO:0061136 |
46 |
0.013
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.013
|
|
|
|
photoreceptor cell differentiation
|
GO:0046530 |
52 |
0.013
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.013
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.012
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.012
|
|
|
|
negative regulation of secretion
|
GO:0051048 |
61 |
0.012
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.012
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.012
|
|
|
|
negative regulation of gene expression epigenetic
|
GO:0045814 |
15 |
0.012
|
|
|
|
macrophage colony stimulating factor signaling pathway
|
GO:0038145 |
2 |
0.012
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.012
|
|
|
|
dna packaging
|
GO:0006323 |
30 |
0.012
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.012
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.012
|
|
|
|
leukocyte homeostasis
|
GO:0001776 |
79 |
0.012
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.012
|
|
|
|
positive regulation of rab gtpase activity
|
GO:0032851 |
7 |
0.012
|
|
|
|
protein dealkylation
|
GO:0008214 |
13 |
0.012
|
|
|
|
ribosomal small subunit biogenesis
|
GO:0042274 |
4 |
0.012
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.012
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.012
|
|
|
|
humoral immune response
|
GO:0006959 |
57 |
0.012
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.012
|
|
|
|
negative regulation of histone modification
|
GO:0031057 |
18 |
0.012
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.012
|
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.012
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.012
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.012
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.012
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.011
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.011
|
|
|
|
transforming growth factor beta2 production
|
GO:0032906 |
2 |
0.011
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.011
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.011
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.011
|
|
|
|
regulation of mrna splicing via spliceosome
|
GO:0048024 |
32 |
0.011
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.011
|
|
|
|
macrophage differentiation
|
GO:0030225 |
20 |
0.011
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.011
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.011
|
|
|
|
positive regulation of b cell proliferation
|
GO:0030890 |
24 |
0.011
|
|
|
|
positive regulation of wnt signaling pathway
|
GO:0030177 |
45 |
0.011
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.011
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.011
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.011
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
15 |
0.011
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.011
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.011
|
|
|
|
male meiosis i
|
GO:0007141 |
16 |
0.011
|
|
|
|
positive regulation of ossification
|
GO:0045778 |
47 |
0.011
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.011
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.011
|
|
|
|
regulation of rna splicing
|
GO:0043484 |
37 |
0.011
|
|
|
|
negative regulation of calcium ion dependent exocytosis
|
GO:0045955 |
3 |
0.011
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.011
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.011
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.010
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.010
|
|
|
|
histone lysine methylation
|
GO:0034968 |
50 |
0.010
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.010
|
|
|
|
attachment of spindle microtubules to kinetochore
|
GO:0008608 |
4 |
0.010
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.010
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.010
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.010
|
|
|
|
granulocyte activation
|
GO:0036230 |
10 |
0.010
|
|
